William Blair & Company’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $626K | Sell |
|
|||||
|
2025
Q2 | $586K | Sell |
|
|||||
|
2025
Q1 | $687K | Sell |
|
|||||
|
2024
Q4 | $881K | Buy |
|
|||||
|
2024
Q3 | $742K | Sell |
|
|||||
|
2024
Q2 | $1.08M | Sell |
|
|||||
|
2024
Q1 | $1.19M | Buy |
|
|||||
|
2023
Q4 | $1.07M | Sell |
|
|||||
|
2023
Q3 | $977K | Sell |
|
|||||
|
2023
Q2 | $1.35M | Sell |
|
|||||
|
2023
Q1 | $31.6M | Buy |
|
|||||
|
2022
Q4 | $8.9M | Buy |
|
|||||
|
2022
Q3 | $1.2M | Buy |
|
|||||
|
2022
Q2 | $1.08M | Buy |
|
|||||
|
2022
Q1 | $987K | Sell |
|
|||||
|
2021
Q4 | $1.31M | Sell |
|
|||||
|
2021
Q3 | $1.93M | Buy |
|
|||||
|
2021
Q2 | $1.94M | Buy |
|
|||||
|
2021
Q1 | $1.91M | Sell |
|
|||||
|
2020
Q4 | $2.9M | Buy |
|